Growth Hormone Deficiency Market

브랜드별(Norditropin, Genotropin, Humatrope, Saizen, Omnitrope 등), 용도별(소아 성장 호르몬 결핍증, 터너 증후군, 특발성 저신장증(ISS), 임신 주수에 비해 작은 성장 호르몬, 성인 성장 호르몬 결핍증, Prader-Willi 증후군 등), 투여 경로별(피하, 정맥, 근육), 유통 채널별(병원 약국, 소매 약국, 온라인 약국, 전문 약국), 지역별(아메리카, 유럽, 아시아 태평양, 중동 및 아프리카 - 2032년까지 예측) 성장 호르몬 결핍증 시장 조사 보고서 정보
ID: MRFR/HC/8950-CR
128 Pages
Rahul Gotadki
Last Updated: July 24, 2026
Growth Hormone Deficiency Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.58%
2024 Market Size$ 4.84 Billion
2025 Market Size$ 5.01 Billion
2035 Market Size$ 7.13 Billion
Key Players
Pfizer
Eli Lilly and Company
Novo Nordisk
Merck KGaA
Sandoz
Ipsen
Opportunities
  • Innovations in Pharmaceutical Treatments
  • Aging Population and Associated Health Issues
  • Rising Prevalence of Growth Hormone Deficiency

Growth Hormone Deficiency Market 요약

Growth Hormone Deficiency Market 시장의 주요 기업은 다음과 같습니다

향후 전망

Growth Hormone Deficiency Market 향후 전망

보고서 범위

FAQs

What is the current valuation of the Growth Hormone Deficiency Market?

The market valuation was 4.84 USD Billion in 2024.

What is the projected market size for the Growth Hormone Deficiency Market by 2035?

The market is projected to reach 7.128 USD Billion by 2035.

What is the expected CAGR for the Growth Hormone Deficiency Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 3.58%.

Which companies are the key players in the Growth Hormone Deficiency Market?

Key players include Pfizer, Eli Lilly and Company, Novo Nordisk, Merck KGaA, Sandoz, Ipsen, Ferring Pharmaceuticals, Hikma Pharmaceuticals, and Amgen.

What are the leading brands in the Growth Hormone Deficiency Market?

Leading brands include Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, and others.

What is the market performance of the Pediatric Growth Hormone Deficiency segment?

The Pediatric Growth Hormone Deficiency segment was valued at 1.2 USD Billion in 2024 and is expected to reach 1.8 USD Billion by 2035.

How does the route of administration impact the Growth Hormone Deficiency Market?
The Intravenous route of administration was valued at 2.14 USD Billion in 2024 and is projected to grow to 3.128 USD Billion by 2035.
What distribution channels are utilized in the Growth Hormone Deficiency Market?
Distribution channels include Hospital Pharmacies, Retail Pharmacies, Clinics, and E-Commerce Websites, with E-Commerce projected to grow from 1.24 USD Billion to 1.83 USD Billion by 2035.
What is the market size for the Adult Growth Hormone Deficiency application?
The Adult Growth Hormone Deficiency application was valued at 1.0 USD Billion in 2024 and is expected to reach 1.5 USD Billion by 2035.
What trends are observed in the Growth Hormone Deficiency Market segments?
Segments such as Intramuscular and Subcutaneous routes are also expected to show growth, indicating a diverse market landscape.
저자
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
무료 샘플 다운로드

이 보고서의 무료 샘플을 받으려면 아래 양식을 작성하십시오

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.